Search research articles
Contact Us
Filters
Showing results (401-410 of 491) with videos related to
Page
of 50
Sort By:
Intensive Care Medicine Experimental
|
December 18, 2020
The effects of tidal volume size and driving pressure levels on pulmonary complement activation: an observational study in critically ill patients
Friso M de Beer, Luuk Wieske, Gerard van Mierlo, et al.
Archives of Dermatological Research
|
February 18, 2004
Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis
Amber Y Goedkoop, Menno A de Rie, Daisy I Picavet, et al.
Archives of Dermatology
|
February 17, 2010
Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis
Lidian L A Lecluse, Rieke J B Driessen, Phyllis I Spuls, et al.
Oncogene
|
April 6, 2004
Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6
Alec C Kimmelman, Rui F Qiao, Goutham Narla, et al.
The British Journal of Dermatology
|
November 5, 2011
Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo
M W Kroon, I C K W Joore, B S Wind, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2013
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis
Hanne F Harbo, Noriko Isobe, Pål Berg-Hansen, et al.
Journal of the American Academy of Dermatology
|
June 1, 1997
Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study
I M Zonneveld, M M Meinardi, T Karlsmark, et al.
Scandinavian Journal of Immunology
|
October 13, 2021
Exploring the role of the multiple sclerosis susceptibility gene CLEC16A in T cells
Anna M Eriksson, Ingvild Sørum Leikfoss, Greger Abrahamsen, et al.
Critical Care (London, England)
|
September 2, 2020
The importance of airway and lung microbiome in the critically ill
Ignacio Martin-Loeches, Robert Dickson, Antoni Torres, et al.
Experimental Dermatology
|
January 22, 2005
Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose?
W-H Boehncke, M P Schön, G Girolomoni, et al.
Page
of 50
Search research articles
Search
Showing results (401-410 of 491) with videos related to
Sort By:
Page
of 50
Intensive Care Medicine Experimental
|
December 18, 2020
The effects of tidal volume size and driving pressure levels on pulmonary complement activation: an observational study in critically ill patients
Friso M de Beer, Luuk Wieske, Gerard van Mierlo, et al.
Archives of Dermatological Research
|
February 18, 2004
Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis
Amber Y Goedkoop, Menno A de Rie, Daisy I Picavet, et al.
Archives of Dermatology
|
February 17, 2010
Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis
Lidian L A Lecluse, Rieke J B Driessen, Phyllis I Spuls, et al.
Oncogene
|
April 6, 2004
Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6
Alec C Kimmelman, Rui F Qiao, Goutham Narla, et al.
The British Journal of Dermatology
|
November 5, 2011
Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo
M W Kroon, I C K W Joore, B S Wind, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2013
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis
Hanne F Harbo, Noriko Isobe, Pål Berg-Hansen, et al.
Journal of the American Academy of Dermatology
|
June 1, 1997
Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study
I M Zonneveld, M M Meinardi, T Karlsmark, et al.
Scandinavian Journal of Immunology
|
October 13, 2021
Exploring the role of the multiple sclerosis susceptibility gene CLEC16A in T cells
Anna M Eriksson, Ingvild Sørum Leikfoss, Greger Abrahamsen, et al.
Critical Care (London, England)
|
September 2, 2020
The importance of airway and lung microbiome in the critically ill
Ignacio Martin-Loeches, Robert Dickson, Antoni Torres, et al.
Experimental Dermatology
|
January 22, 2005
Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose?
W-H Boehncke, M P Schön, G Girolomoni, et al.
Page
of 50